ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Red Cell Distribution Width/Albumin Ratio as a Valuable Marker to Predict Spontaneous Recanalization in Acute ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study.
Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Red Cell Distribution Width/Albumin Ratio in STEMI: Biologically Plausible but Clinically Unproven.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/HemostasisArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundThis study aimed to evaluate the predictive value of the red cell distribution width/ albumin ratio (RDW/ALB ratio, RAR) for spontaneous recanalization (SR) in patients with acute ST-segment elevation myocardial infarction (STEMI).MethodsWe conducted a retrospective analysis of 353 patients diagnosed with STEMI who were admitted to our institution between January 2019 and April 2022. Based on the thrombolysis in myocardial infarction (TIMI) flow grades in the infarct-related artery (IRA), the patients were divided into two groups: a non-spontaneous recanalization (NSR) group (TIMI 0-1; n = 230) and an SR group (TIMI 2-3; n = 123). The RAR was calculated for each patient, and its association with SR was evaluated using binary logistic regression and receiver operating characteristic (ROC) curve analysis. Results are presented as odds ratios (OR) with 95% confidence intervals (CI).ResultsPatients in the NSR group had a significantly higher RAR level compared to the SR group (3.34 [3.11, 3.64] vs. 3.18 [2.95, 3.45], P < 0.001). In the multivariable logistic regression analysis adjusted for key confounders including sex, age, white blood cell (WBC), apolipoprotein A1(ApoA1), albumin (ALB), and left ventricular ejection fraction (LVEF), a higher RAR remained an independent predictor for the absence of SR (OR = 2.528, 95% CI: 1.019-6.276). The predictive performance of RAR for SR was modest, with an area under the ROC curve of 0.613 (95% CI: 0.552-0.675), yielding a sensitivity of 53.9% and a specificity of 67.0%.ConclusionOur findings suggest that RAR is a promising biomarker for predicting SR in patients with acute STEMI. It helps us to identify high-risk populations in acute STEMI without SR at an early stage, thereby enhancing our ability for early intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.